RWM
CLX icon

Revisor Wealth Management’s Clorox CLX Stock Holding History

Revisor Wealth Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Buy
2,621
+396
+18% +$38K 0.06% 323
2026
Q1 		$234K Sell
2,225
-85
-4% -$9.64K 0.06% 296
2025
Q4 		$260K Sell
2,310
-254
-10% -$27.6K 0.07% 264
2025
Q3 		$310K Sell
2,564
-317
-11% -$39.3K 0.11% 201
2025
Q2 		$370K Buy
2,881
+192
+7% +$25.6K 0.13% 185
2025
Q1 		$396K Buy
2,689
+1,215
+82% +$186K 0.18% 147
2024
Q4 		$238K Sell
1,474
-729
-33% -$119K 0.22% 100
2024
Q3 		$359K Sell
2,203
-111
-5% -$16.4K 0.22% 109
2024
Q2 		$316K Sell
2,314
-1,842
-44% -$256K 0.22% 110
2024
Q1 		$615K Buy
4,156
+2,345
+129% +$350K 0.28% 91
2023
Q4 		$258K Sell
1,811
-560
-24% -$74.7K 0.3% 95
2023
Q3 		$311K Buy
2,371
+601
+34% +$91.3K 0.26% 104
2023
Q2 		$282K Sell
1,770
-182
-9% -$29.4K 0.25% 116
2023
Q1 		$309K Buy
+1,952
New +$293K 0.28% 93

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Revisor Wealth Management's CLX Position: Q2 2026 in Review

Revisor Wealth Management increased its Clorox (CLX) stake by 18% in Q2 2026, buying an estimated $38K and bringing the position to 2,621 shares worth $250K. The position accounts for 0.06% of the portfolio, ranked #323.

Revisor Wealth Management first reported a position in CLX in Q1 2023 and has held it in 14 quarters since. The position peaked at $615K in Q1 2024. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Revisor Wealth Management held 2,621 shares of Clorox worth $250K as of Q2 2026.
  • Revisor Wealth Management bought 396 Clorox shares in Q2 2026, an estimated $38K.
  • Clorox made up 0.06% of Revisor Wealth Management's portfolio in Q2 2026, its #323 holding.
  • Revisor Wealth Management first reported a position in Clorox in Q1 2023 and has held it in 14 quarters since.
  • Revisor Wealth Management's Clorox position peaked at $615K in Q1 2024.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.